The present invention relates to an in vitro method for determining the ability of a vaccine composition which comprises one or more antigens or a nucleic acid molecule which encodes one or more antigens to stimulate a T cell response. In one embodiment, the method comprises the steps of: (1) contacting...http://www.google.es/patents/US20010055752?utm_source=gb-gplus-sharePatente US20010055752 - Predictive assay for immune response
Número de solicitud: 09/782,709 Número de publicación: US 2001/0055752 A1 Fecha de presentación: 13 Feb 2001 Patente emitida: US6627407 ( Fecha de emisión 30 Sep 2003)